Download the appMore options
PisaczekSearch
文AEN
Vitamins and minerals

Autumn blues and sadness? Watch out for low vitamin D levels!

Sources: 15 · Article: 18 249 characters ↓

What do Natural Therapy Specialists write?

Jan Jaśkowski

Depression is described as a problem influenced by several factors, including vitamin D levels.

„Increasing evidence suggests that other factors are extremely important, such as the body's metabolic processes, inflammation, vitamin D levels, and, indirectly, physical activity and lifestyle. Therefore, a sensible approach is to support the body in many ways—through exercise, a suitable diet, exposure to sunlight, thyroid tests, and supplements that support cellular energy production, such as vitamin D3 and creatine.”Coraz więcej dowodów wskazuje, że ogromne znaczenie mają inne czynniki, takie jak procesy metaboliczne organizmu, stany zapalne, poziom witaminy D, a pośrednio także aktywność fizyczna i styl życia. Dlatego rozsądnym podejściem jest wszechstronne wsparcie organizmu – poprzez ruch, odpowiednią dietę, ekspozycję na słońce, badania tarczycy, a także suplementy wspierające energetykę komórkową, takie jak witamina D3 i kreatyna.
Jan Jaśkowski

Low vitamin D levels have been linked to more frequent depression, and supplementation is said to help treat it.

„Vitamin D also affects mental well-being. Many older people live alone and have chronic illnesses. This affects their mental health and is a frequent cause of depression. Low vitamin D levels have been linked to depression occurring more often, and supplementation helps treat depression.”Witamina D ma również wpływ na nastrój psychiczny. Wielu seniorów żyje samotnie i jest przewlekle schorowana. To odbija się na ich psychice i jest częstą przyczyną depresji. Powiązano niski poziom witaminy D z częstszym występowaniem depresji, a jej suplementacja pomaga w leczeniu depresji.
Jan Jaśkowski

Exercise, a suitable diet, and exposure to sunlight are listed as ways to support the body in many ways.

„Therefore, a sensible approach is to support the body in many ways—through exercise, a suitable diet, exposure to sunlight, thyroid tests, and supplements that support cellular energy production, such as vitamin D3 and creatine. In the next article in the series, Jan Jaśkowski will describe further ways to support mental health and strengthen psychological resilience.”Dlatego rozsądnym podejściem jest wszechstronne wsparcie organizmu – poprzez ruch, odpowiednią dietę, ekspozycję na słońce, badania tarczycy, a także suplementy wspierające energetykę komórkową, takie jak witamina D3 i kreatyna. W następnym artykule w serii Jan Jaśkowski opisze kolejne metody wspierania zdrowia psychicznego i wzmacniania odporności psychicznej.
Jerzy Jaśkowski

Vitamin D3 was identified as a possible treatment for depression.

„Scientific papers available on PubMed, the so-called official ones, clearly indicate that, for example, depression can be treated by taking vitamin D-3. Could this be a sign of the backwardness of medicine in Poland, or is it a deliberate action by officials? The fact that the teaching of biochemistry, especially the cholesterol pathway, was eliminated at medical universities supports the latter possibility.”Dostępne na PubMed prace naukowe, tzw. oficjalne, jednoznacznie wskazują, że np. depresja może być leczona przyjmowaniem wit. D-3. Czyżby to był jeden z objawów zacofania medycyny w Polsce, czy też celowa działalność urzędników? Za tą drugą opcją przemawia fakt zlikwidowania nauczania przedmiotu biochemii, a szczególnie szlaku cholesterolowego na uniwersytetach medycznych.

What does scientific research from PubMed · Europe PMC say?

We selected 9 studies with the best, positive results. This is a selection, not a full review of all research.

Total number of studies on this topic in PubMed: 31.

Aim of the study: Seasonal mood changes occur along a continuum between individuals, with anxiety and depression increasing during the winter months. An extreme form of seasonality appears as the clinical syndrome of seasonal affective disorder (SAD), with carbohydrate cravings, excessive sleep, lethargy, and changes in circadian rhythms also evident.

Results: It has been suggested that seasonality and the symptoms of SAD may be due to changing levels of vitamin D3, the hormone of sunlight, which lead to changes in brain serotonin. Forty-four healthy subjects were given 400 IU, 800 IU, or no vitamin D3 for 5 days during late winter in a randomized, double-blind study. Results from a self-report measure showed that vitamin D3 significantly improved positive mood, and there was some evidence of a reduction in negative mood. The results are discussed in terms of their implications for seasonality, SAD, serotonin, food preference, sleep, and circadian rhythms.

Money for the studynot stated
Do the authors have ties to companies?not stated
Did a manufacturer help with the study?unknown
Type of studystudy with random allocation to groups (RCT)

“Not stated” does not mean nobody paid — the database does not always record it.

Aim of the study: Few studies have investigated whether vitamin D insufficiency is linked to depression in healthy young women, despite the high rates of both problems among women. Female undergraduates (n=185) living in the Pacific Northwest during the fall, winter, and spring academic terms completed the Center for Epidemiologic Studies Depression (CES-D) scale weekly for 4 weeks (W1-W5).

Results: Winter and Spring) were explained by their higher levels of vitamin D3. W1 depressive symptoms did not predict change in vitamin D3 levels from W1 to W5. The findings are consistent with a temporal association between low vitamin D levels and clinically meaningful depressive symptoms. The preventive value of supplementation should be studied further.

Money for the studycompany together with others · National Institute of Environmental Health Sciences (NIEHS), NIEHS NIH HHS, John C. Erkkila, M.D. Endowment for Health and Human Performance of Good Samaritan Hospital Foundation
Do the authors have ties to companies?not stated
Did a manufacturer help with the study?NO
Type of studyobservation of people
Participants185

“Not stated” does not mean nobody paid — the database does not always record it.

Aim of the study: This integrative review evaluates research studies that investigated the association between vitamin D and mood disorders affecting women to determine whether further research comparing these variables is warranted. A literature search using the CINAHL, PsycINFO, MEDLINE, and PubMed databases was conducted to find peer-reviewed mood disorder research studies that measured serum 25-hydroxyvitamin D (25[OH]D) levels.

Results: This integrative review evaluates research studies that investigated the association between vitamin D and mood disorders affecting women to determine whether further research comparing these variables is warranted. A literature search using the CINAHL, PsycINFO, MEDLINE, and PubMed databases was conducted to find peer-reviewed mood disorder research studies that measured serum 25-hydroxyvitamin D (25[OH]D) levels. Four of the six studies reviewed reported significant results, with all four showing an association between low 25(OH)D levels and higher rates of four mood disorders: premenstrual syndrome, seasonal affective disorder, unspecified mood disorder, and major depressive disorder. This review indicates a possible biochemical mechanism linking vitamin D and mood disorders affecting women, warranting further studies of these variables using rigorous methods.

Money for the studygovernment, public institutions · NICHD NIH HHS
Do the authors have ties to companies?not stated
Did a manufacturer help with the study?NO
Type of studydiscussion of other studies

“Not stated” does not mean nobody paid — the database does not always record it.

Aim of the study: Vitamin D plays an important role in calcium and bone mineral metabolism and also affects cardiovascular, psychological, and cognitive functions. The ultraviolet B radiation component of sunlight, which varies markedly by season in Antarctica, influences vitamin D synthesis. Depression and mood disorders are associated with this extreme light-dark cycle.

Results: Mild vitamin D deficiency was present in two (10 %) subjects on arrival, increasing to seven (35 %) subjects during the polar winter at 6 months. The mean score on the BDI-II depression screening measure was significantly higher in midwinter (4.8 ± 3.9) than at baseline (2.9 ± 2.1). Only 2/20 (10 %) of the subjects met the criteria for minor depression. Higher PTH levels at 6 months correlated with a higher PANAS X score (p = 0.021). Mean calcium, inorganic phosphorus, and ALP levels were comparable over the course of the expedition. Low light exposure during the dark polar winter, lower vitamin D, and increased intact PTH levels were found to be associated with depression during 1 year of residence in Antarctica. Low dietary intake and reduced exposure to solar radiation during the polar winter lower serum vitamin D levels in otherwise healthy individuals, suggesting that supplementation may be necessary.

Money for the studynot stated
Do the authors have ties to companies?not stated
Did a manufacturer help with the study?unknown
Type of studyobservation of people
Participants20

“Not stated” does not mean nobody paid — the database does not always record it.

Aim of the study: The role of vitamin D in the pathophysiology of depression has sparked interest in its potential as a biomarker in mental health. Given the limited data on this association in the Romanian population, this study aimed to assess the correlation between vitamin D status and the severity of depressive symptoms in a sample of adult patients from Romania.

Results: A statistically significant negative association was identified for the BDI-II scale (B = -0.3170444, β = -0.2621328, p = 0.007) and the HAM-D17 scale (B = -0.1495026, β = -0.2829461, p = 0.002), and this remained robust after adjustment for covariates (BDI-II: B = -0.2110473, β = -0.1744942, p = 0.050; HAMD17: B = -0.1153659, β = -0.2183397, p = 0.018). Compared with subjects with vitamin D deficiency, those with sufficient levels had a significantly lower probability of belonging to higher depression severity categories on both scales (BDI-II: coefficient = -0.6855429, p = 0.004; HAM-D17: coefficient = -0.7029572, p = 0.005). The study found a statistically significant negative correlation between vitamin D status and depression severity, which remained after adjustment for covariates. Sufficient vitamin D levels were associated with a significantly lower probability of belonging to a higher depression severity category compared with vitamin D deficiency.

Money for the studyuniversity or foundation · University of Oradea
Do the authors have ties to companies?no — the authors say so
Did a manufacturer help with the study?NO
Type of studyobservation of people
Participants90

“Not stated” does not mean nobody paid — the database does not always record it.

Aim of the study: Major depressive disorder (MDD) is a common psychiatric condition characterized by depressive symptoms and clinical features related to suicide. Vitamin D status has been investigated as a potential clinical correlate of depression and suicidal ideation, but the direction and specificity of these associations remain uncertain.

Results: Vitamin D deficiency was observed in 61.9% of participants, and the mean serum 25(OH)D level was 18.4 ± 11.9 ng/mL. Lower serum 25(OH)D levels were significantly associated with higher HDRS, SIS, and SPS total and subscale scores. In adjusted models, higher serum 25(OH)D levels remained inversely associated with HDRS scores, SIS scores, and total SPS scores. Being a parent was also associated with lower SIS scores, while a history of suicide attempts was associated with higher SPS-Suicidal Ideation scores. Lower serum 25(OH)D levels were associated with more severe depressive symptoms and higher scores on suicide-related scales in adults with MDD, particularly in cognitive-affective areas relevant to suicide risk.

Money for the studynot stated
Do the authors have ties to companies?no — the authors say so
Did a manufacturer help with the study?NO
Type of studyobservation of people
Participants97

“Not stated” does not mean nobody paid — the database does not always record it.

Aim of the study: Although recent laboratory studies have greatly advanced our understanding of how vitamin D acts in the brain, much remains unknown about how vitamin D relates to mood. The few epidemiological studies on vitamin D and depression have produced inconsistent results and generally had substantial methodological limitations.

Results: The few epidemiological studies on vitamin D and depression have produced inconsistent results and generally had substantial methodological limitations. Recent findings from a randomized trial suggest that high doses of vitamin D supplements may improve mild depressive symptoms, but important questions remain about how vitamin D may affect monoamine function and the hypothalamic-pituitary-adrenal axis response to stress, whether vitamin D supplementation can improve mood in people with moderate-to-severe depression, and whether sufficient vitamin D levels protect against the onset or recurrence of depression. At this time, it is premature to conclude that vitamin D status is related to the occurrence of depression. Further prospective studies of this relationship are essential.

Money for the studygovernment, public institutions · NIMH NIH HHS
Do the authors have ties to companies?not stated
Did a manufacturer help with the study?NO
Type of studydiscussion of other studies

“Not stated” does not mean nobody paid — the database does not always record it.

Aim of the study: Depression affects 5% of the global population, posing significant health and economic challenges. This study evaluates the effectiveness of vitamin D supplementation in reducing depressive symptoms and explores its dose-response relationship.

Results: The outcomes were reported in 15 studies comprising data from 962 participants. Vitamin D supplementation significantly improved depressive symptoms compared with the placebo group (SMD: -0.98; 95% CI - 1.28 to -0.68; p < 0.001). Statistical heterogeneity was high (I2 = 79%; p < 0.001). Secondary outcomes showed significant reductions in serum PTH (MD: -4.19; 95% CI - 8.18 to -0.2 pg./mL) and TNFα levels (MD: -0.3; 95% CI - 0.44 to -0.16 pg./mL) in the intervention groups, while other outcomes, such as BMI, weight, and IL-6, showed no significant changes. Dose-response analysis further indicated that higher daily doses of vitamin D, particularly up to 5,000 IU/day, were associated with the greatest reduction in depressive symptoms. Our findings from this systematic review and meta-analysis indicate that vitamin D supplementation may be an effective add-on therapy for improving depressive symptoms.

Money for the studynot stated
Do the authors have ties to companies?no — the authors say so
Did a manufacturer help with the study?NO
Type of studyreview of many studies

“Not stated” does not mean nobody paid — the database does not always record it.

Aim of the study: Vitamin D deficiency and depressive disorders are both common in patients with eating disorders (EDs). However, the association between vitamin D status and current depressive disorder (CDD) in people with EDs remains insufficiently explored.

Results: Vitamin D deficiency was significantly associated with higher odds of CDD (OR 1.98, 95% CI 1.20-3.28; p = 0.008). This association persisted after adjustment for ED severity, psychiatric comorbidities, and season of assessment. No significant interactions were found between vitamin D deficiency and eating-disorder subtype, EDE-Q score, or season. Vitamin D deficiency was associated with the presence of a current depressive disorder in patients with eating disorders, independently of ED subtype, severity, and seasonality. These findings support the clinical relevance of assessing vitamin D status in patients with EDs who present with depressive symptoms. Longitudinal studies are needed to clarify the direction and clinical implications of this association.

Money for the studynot stated
Do the authors have ties to companies?no — the authors say so
Did a manufacturer help with the study?NO
Type of studyobservation of people
Participants481

“Not stated” does not mean nobody paid — the database does not always record it.

What do orthomolecular medicine doctors write?

Orthomolecular Medicine News Service
„(2013) Therapeutic effects of vitamin D as adjunctive therapy to fluoxetine in patients with major depressive disorder. Aust N Z J Psychiatry 47:271-275. Jazayeri S, Tehrani-Doost M, Keshavarz SA, et al. (2008) Comparison of therapeutic effects of omega-3 fatty acid eicosapentaenoic acid and fluoxetine, separately and in combination, in major depressive disorder. Aust N Z J Psychiatry 42:192-198. DiNicolantonio JJ, O'Keefe JH. (2021) Magnesium and Vitamin D Deficiency as a Potential Cause of Immune Dysfunction, Cytokine Storm and Disseminated Intravascular Coagulation in covid-19 patients. Mo Med. 118:68-73. Pizzorno L, Pizzorno J.”(2013) Therapeutic effects of vitamin D as adjunctive therapy to fluoxetine in patients with major depressive disorder. Aust N Z J Psychiatry 47:271-275. Jazayeri S, Tehrani-Doost M, Keshavarz SA, et al. (2008) Comparison of therapeutic effects of omega-3 fatty acid eicosapentaenoic acid and fluoxetine, separately and in combination, in major depressive disorder. Aust N Z J Psychiatry 42:192-198. DiNicolantonio JJ, O'Keefe JH. (2021) Magnesium and Vitamin D Deficiency as a Potential Cause of Immune Dysfunction, Cytokine Storm and Disseminated Intravascular Coagulation in covid-19 patients. Mo Med. 118:68-73. Pizzorno L, Pizzorno J.
Orthomolecular Medicine News Service
„Taking 1,000 mg of vitamin B-3 three times a day often cures mild to moderate depression. Dramatic results are often achieved within one week of starting this nutritional program, especially in alcoholics. It is recommended that you always work with your physician on any health program. Sometimes a simple vitamin D deficiency causes depression. 3,000 I.U./day from all sources can alleviate the problem. (2) 3,000 mg/day or more of niacin (vitamin B-3), along with the same quantity of vitamin C, taken in divided doses throughout the day can successfully treat both schizophrenia and bipolar disorder.”Taking 1,000 mg of vitamin B-3 three times a day often cures mild to moderate depression. Dramatic results are often achieved within one week of beginning this nutritional program, especially in alcoholics. It is recommended that you always work with your physician with any health program. Sometimes a simple deficiency of vitamin D causes depression. 3,000 I.U./day from all sources can alleviate the problem. (2) 3,000 mg/day or more of niacin (vitamin B-3), along with the same quantity of vitamin C, taken in divided doses throughout the day can successfully treat both schizophrenia and bipolar disorder.
Orthomolecular Medicine News Service
„(2022) The Effect of Vitamin D Supplementation on Symptoms of Depression in Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Acta Med Indones. 54:574-584. Omidian M, Mahmoudi M, Abshirini M, et al.”(2022) The Effect of Vitamin D Supplementation on Symptoms of Depression in Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Acta Med Indones. 54:574-584. Omidian M, Mahmoudi M, Abshirini M, et al.

Sources (15)

Pisaczek does not judge who is right. It shows what was written and where to read it. Every sentence above has its source.